raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79085

AKT2-related familial partial lipodystrophy

Synonyms: AKT2-related FPLD

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy and severe insulin resistance in the liver and peripheral tissues, hyperinsulinemia, and diabetes mellitus. Acanthosis nigricans and hypertension have been reported in association.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAKT2-related familial partial lipodystrophyAKT2-related FPLD
frLipodystrophie partielle familiale associée à AKT2LDPF associée à AKT2
deLipodystrophie, familiäre partielle, durch AKT2-GenmutationAKT2-abhängige FPLD · FPLD1
esLipodistrofia parcial familiar asociada a AKT2FPLD asociada a AKT2
itLipodistrofia familiare parziale AKT2-correlataFPLD AKT2-correlata
nlAKT2-gerelateerde familiale partiële lipodystrofieAKT2-gerelateerde FPLD
ptLipodistrofia parcial familiar AKT2-relacionada
plRodzinna lipodystrofia częściowa zależna od AKT2FplD zależna od AKT2
csAKT2-vázaná familiární parciální lipodystrofieAKT2-vázaná FPLD
ukСімейна часткова ліподистрофія, повязана з AKT2FPLD, повязана з AKT2
zhAKT2相关性家族性部分脂肪营养障碍AKT2相关性家族性FPLD
trAKT2-ilişkili ailesel kısmi lipodistrofiAKT2-ilişkili FPLD

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10E88.1NTBTattributedvalidated
ICD-115A44NTBTindexvalidated
MONDO0019192Evalidated
UMLSC5680134Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AKT2Disease-causing germline mutation(s) inAssessedHGNC:392ENSG0000010522116473119q13.2AKT serine/threonine kinase 216409151[PMID]_21865368[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families1 familiesWorldwideFamily(ies)Validated16409151[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

12 annotations · validated 2017-01-02
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0000855Insulin resistance
HP:0009125Lipodystrophy
Very frequent (99-80%)
HP:0000956Acanthosis nigricans
HP:0030685Decreased adiponectin level
HP:0003292Decreased serum leptin
HP:0001397Hepatic steatosis
HP:0002240Hepatomegaly
HP:0002155Hypertriglyceridemia
HP:0008993Increased intraabdominal fat
Frequent (79-30%)
HP:0000831Insulin-resistant diabetes mellitus
HP:0000876Oligomenorrhea
HP:0000147Polycystic ovaries

Run the differential on the 9 obligate / very frequent terms

Annotation source: 15166380[PMID]_17327441[PMID]_17554339[PMID]_21865368[PMID]_22748602[PMID]

7

Sources for this card